|
|
|
41
|
6451AE
|
4-QUIN D 0.1%|0.5% EYE DR (HAN) DEXAMETHASONE|MOXIFLOXACIN (BQ)
|
DEXAMETHASONE|MOXIFLOXACIN
|
4-QUIN D
|
5ML
|
BQ
|
3.94
|
3.9416
|
BOTT
|
1
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6451Z
|
VIGADEXA 0.1% | 0.5% EYE DR (NVS/COL) DEXAMETHA
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
BQ
|
20.39
|
20.39
|
EYE DROP
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6451Z
|
VIGADEXA 0.1%|0.5% EYE DR (NVS) DEXAMETHASONE|MOXIFLOXACIN (C)
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
C
|
20.39
|
20.3874
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6451Z
|
VIGADEXA 0.1%|0.5% EYE DR (NVS) DEXAMETHASONE|MOXIFLOXACIN
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
C
|
20.39
|
20.39
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|